Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital health program could transform diabetes care for seniors with multiple illnesses

NCT ID NCT07310849

Disease control Sponsor: Chang Gung University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study tests a 6-month digital care program for adults aged 50+ with type 2 diabetes and at least one other chronic condition like high blood pressure or kidney disease. The program combines online education, phone support, a mobile health app, home visits, and personalized care plans. Researchers will track whether it improves disease control, self-management, depression, and quality of life compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital Care Community Common Good program (behavioral intervention including online and in-person education, telephone care, mHealth platform, home visits, and individualized care plans)
What this could lead to
If successful, this program could provide a practical, community-based approach to improve self-management and quality of life for older adults with diabetes and multiple chronic conditions.
What could go wrong
This is a small, early-stage study (169 participants) focused on behavioral changes, not a drug or cure. Results may not apply to other populations or settings, and improvements may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 169 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age and Consent: Individuals aged 50 years or older who are willing to provide written informed consent. * Language and Literacy: Participants must be literate and able to communicate in Mandarin or Taiwanese. * Medical Diagnosis: Participants must have a physician-confirmed diagnosis of type 2 diabetes mellitus (T2DM) and at least one comorbid chronic disease (e.g., hypertension, hyperlipidemia, chronic kidney disease, or heart disease). * Technology Use: Participants must own a smartphone and be willing to use the LINE messaging app and web-based health education links. * Residence: Participants must reside within one of the four participating communities and have no plans to move away during the study intervention period. Exclusion Criteria: * Those with severe diabetes-related complications, such as renal failure, cerebrovascular disease, diabetic foot, or retinopathy. * Individuals with psychiatric disorders, undergoing active cancer treatment, or those unable to perform independent self-care (e.g., due to visual impairment or mobility limitations). * Individuals without diabetes but with other chronic diseases. * Individuals residing in long-term care institutions. * Individuals who are simultaneously participating in other intervention programs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardio vascular disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arthritis, Gouty cardiovascular disorder chronic kidney disease diabetes mellitus Dyslipidemias gout heart disorder hyperlipidemia hypertensive disorder inherited lipid metabolism disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardio vascular disease CKD Dyslipidemia Gout arthritis Hypertension TYPE2DIABETES

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wugu District Public Health Center,

    RECRUITING

    New Taipei City, Wugu District, 248524, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.